Kevin is fighting infection for the team.
We’re happy to be on his defensive line.
Appili Therapeutics CEO Kevin Sullivan and his team are developing new ways to fight infectious disease, still the leading cause of death worldwide.
Today the company is focused on two drugs. The first removes the awful taste from an existing antibiotic that treats a serious stomach infection known as C-difficile in children. Kids are obviously more willing to take a better-tasting drug, making the treatment more effective.